Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Millward

Showing results (201-210 of 224) with videos related to

Pageof 23
Sort By:
Public Health Nutrition|July 24, 2008
Comparison of the effects of four commercially available weight-loss programmes on lipid-based cardiovascular risk factorsL M Morgan, B A Griffin, D J Millward, et al.
Cancer Epidemiology|April 7, 2015
The aggregation of early-onset melanoma in young Western Australian familiesS V Ward, J G Dowty, R J Webster, et al.
Nature Immunology|July 26, 2022
Lymph node homeostasis and adaptation to immune challenge resolved by fibroblast network mechanicsHarry L Horsnell, Robert J Tetley, Henry De Belly, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 8, 2010
A novel prognostic model for malignant mesothelioma incorporating quantitative FDG-PET imaging with clinical parametersAnna K Nowak, Roslyn J Francis, Michael J Phillips, et al.
Nature Protocols|April 3, 2020
Bilateral murine tumor models for characterizing the response to immune checkpoint blockadeRachael M Zemek, Vanessa S Fear, Cath Forbes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Phase I trial of docetaxel and cisplatin in previously untreated patients with advanced non-small-cell lung cancerM J Millward, J Zalcberg, J F Bishop, et al.
Investigational New Drugs|September 25, 2007
A phase II study of the heparanase inhibitor PI-88 in patients with advanced melanomaKarl D Lewis, William A Robinson, Michael J Millward, et al.
Lung Cancer (Amsterdam, Netherlands)|June 22, 2013
A phase II clinical trial of the vascular disrupting agent BNC105P as second line chemotherapy for advanced Malignant Pleural MesotheliomaAnna K Nowak, Chris Brown, Michael J Millward, et al.
Bone Marrow Transplantation|April 1, 1999
Ifosfamide in combination with paclitaxel or doxorubicin: regimens which effectively mobilize peripheral blood progenitor cells while demonstrating anti-tumor activity in patients with metastatic breast cancerH M Prince, J Gardyn, M J Millward, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|February 11, 2010
Tissue section AFM: In situ ultrastructural imaging of native biomoleculesHelen K Graham, Nigel W Hodson, Judith A Hoyland, et al.
Pageof 23

Showing results (201-210 of 224) with videos related to

Sort By:
Pageof 23
Public Health Nutrition|July 24, 2008
Comparison of the effects of four commercially available weight-loss programmes on lipid-based cardiovascular risk factorsL M Morgan, B A Griffin, D J Millward, et al.
Cancer Epidemiology|April 7, 2015
The aggregation of early-onset melanoma in young Western Australian familiesS V Ward, J G Dowty, R J Webster, et al.
Nature Immunology|July 26, 2022
Lymph node homeostasis and adaptation to immune challenge resolved by fibroblast network mechanicsHarry L Horsnell, Robert J Tetley, Henry De Belly, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 8, 2010
A novel prognostic model for malignant mesothelioma incorporating quantitative FDG-PET imaging with clinical parametersAnna K Nowak, Roslyn J Francis, Michael J Phillips, et al.
Nature Protocols|April 3, 2020
Bilateral murine tumor models for characterizing the response to immune checkpoint blockadeRachael M Zemek, Vanessa S Fear, Cath Forbes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Phase I trial of docetaxel and cisplatin in previously untreated patients with advanced non-small-cell lung cancerM J Millward, J Zalcberg, J F Bishop, et al.
Investigational New Drugs|September 25, 2007
A phase II study of the heparanase inhibitor PI-88 in patients with advanced melanomaKarl D Lewis, William A Robinson, Michael J Millward, et al.
Lung Cancer (Amsterdam, Netherlands)|June 22, 2013
A phase II clinical trial of the vascular disrupting agent BNC105P as second line chemotherapy for advanced Malignant Pleural MesotheliomaAnna K Nowak, Chris Brown, Michael J Millward, et al.
Bone Marrow Transplantation|April 1, 1999
Ifosfamide in combination with paclitaxel or doxorubicin: regimens which effectively mobilize peripheral blood progenitor cells while demonstrating anti-tumor activity in patients with metastatic breast cancerH M Prince, J Gardyn, M J Millward, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|February 11, 2010
Tissue section AFM: In situ ultrastructural imaging of native biomoleculesHelen K Graham, Nigel W Hodson, Judith A Hoyland, et al.
Pageof 23